NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
NeoImmuneTech
NeoImmuneTech
Hoffmann-La Roche
Eli Lilly and Company
Hoffmann-La Roche
Sumitomo Pharma America, Inc.
Hoffmann-La Roche
Revolution Medicines, Inc.
Daiichi Sankyo